May 12, 2020

Systematic Review and Meta-analysis of the Effectiveness and Safety of Hydroxychloroquine in COVID-19.

MedRxiv : the Preprint Server for Health Sciences
T.-H. YangYuh-Lih Chang

Abstract

Backgrounds. Since COVID-19 outbreak, various agents have been tested but no proven effective therapies have been identified. This has led to a lot of controversies among associated researches. Hence, in order to address the issue of using hydroxychloroquine in treating COVID-19 patients, we conducted a systematic review and meta-analysis. Methods. A thorough search was carried out to find relevant studies in MEDLINE, medRxiv, PubMed, Cochrane Database, China Academic Journals Full-text Database and Web of Science. Two investigators independently reviewed 274 abstracts and 23 articles. The trials which evaluated hydroxychloroquine for treatment of COVID-19 were included for this systematic review. Two investigators assessed quality of the studies and data extraction was done by one reviewer and cross checked by the other. Results. Five trials involving 677 patients were included while conducting the meta-analysis. Compared with the control group, hydroxychloroquine with or without azithromycin showed benefits in positive-to-negative conversion of SARS-CoV-2 (odds ratio [OR], 1.95 [95% CI,0.19 to 19.73] and a reduction in progression rate (OR, 0.89 [95% CI, 0.58 to 1.37]), but without demonstrating any statistical significance. ...Continue Reading

  • References
  • Citations

References

  • We're still populating references for this paper, please check back later.
  • References
  • Citations

Citations

  • This paper may not have been cited yet.

Mentioned in this Paper

A 19
Research Personnel
Reviewer (Person)
Study
PubMed
Data Extraction
Hydroxychloroquine
Meta Analysis (Statistical Procedure)
Agent
Clinical Trials

Related Feeds

BioRxiv & MedRxiv Preprints

BioRxiv and MedRxiv are the preprint servers for biology and health sciences respectively, operated by Cold Spring Harbor Laboratory. Here are the latest preprint articles (which are not peer-reviewed) from BioRxiv and MedRxiv.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Related Papers

Annals of the Rheumatic Diseases
Flavio L Heldwein, Adriano Calado
Australian Journal of General Practice
Heather G Mack
BMJ : British Medical Journal
Robin E Ferner, Jeffrey K Aronson
Journal of the American Academy of Dermatology
Muskaan SachdevaRoni P Dodiuk-Gad
Journal of the American Academy of Dermatology
Jane M Grant-Kels
© 2020 Meta ULC. All rights reserved